Joel G. Berger

983 total citations
36 papers, 743 citations indexed

About

Joel G. Berger is a scholar working on Organic Chemistry, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Joel G. Berger has authored 36 papers receiving a total of 743 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Organic Chemistry, 16 papers in Molecular Biology and 9 papers in Cellular and Molecular Neuroscience. Recurrent topics in Joel G. Berger's work include Receptor Mechanisms and Signaling (8 papers), Neurotransmitter Receptor Influence on Behavior (6 papers) and Synthesis and Reactions of Organic Compounds (5 papers). Joel G. Berger is often cited by papers focused on Receptor Mechanisms and Signaling (8 papers), Neurotransmitter Receptor Influence on Behavior (6 papers) and Synthesis and Reactions of Organic Compounds (5 papers). Joel G. Berger collaborates with scholars based in United States, Poland and Germany. Joel G. Berger's co-authors include Richard E. Chipkin, A Barnett, Louis C. Iorio, Kurt Mislow, Lester Friedman, Richard McQuade, Vicki L. Coffin, John W. Clader, William Billard and Richard W. Chapman and has published in prestigious journals such as Journal of the American Chemical Society, Biochemistry and Pain.

In The Last Decade

Joel G. Berger

34 papers receiving 669 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joel G. Berger United States 17 318 288 274 61 56 36 743
William J. Houlihan United States 20 413 1.3× 561 1.9× 247 0.9× 51 0.8× 38 0.7× 73 1.1k
A. Walser United States 16 269 0.8× 434 1.5× 134 0.5× 54 0.9× 24 0.4× 55 792
Jan W. F. Wasley Switzerland 17 483 1.5× 455 1.6× 264 1.0× 27 0.4× 43 0.8× 39 1.1k
Clare O. Kneen United Kingdom 12 346 1.1× 385 1.3× 199 0.7× 42 0.7× 19 0.3× 21 735
Waclaw J. Rzeszotarski United States 21 541 1.7× 185 0.6× 290 1.1× 63 1.0× 21 0.4× 46 980
Graham J. Durant United States 18 478 1.5× 443 1.5× 156 0.6× 83 1.4× 50 0.9× 32 960
Sham S. Nikam United States 18 339 1.1× 310 1.1× 207 0.8× 35 0.6× 35 0.6× 28 696
Klaus P. Bøgesø Denmark 16 392 1.2× 266 0.9× 398 1.5× 65 1.1× 35 0.6× 31 808
Steven Dabbs United States 13 401 1.3× 244 0.8× 269 1.0× 30 0.5× 30 0.5× 20 664
Martyn C. Pritchard United Kingdom 21 705 2.2× 376 1.3× 430 1.6× 45 0.7× 36 0.6× 49 1.1k

Countries citing papers authored by Joel G. Berger

Since Specialization
Citations

This map shows the geographic impact of Joel G. Berger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joel G. Berger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joel G. Berger more than expected).

Fields of papers citing papers by Joel G. Berger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joel G. Berger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joel G. Berger. The network helps show where Joel G. Berger may publish in the future.

Co-authorship network of co-authors of Joel G. Berger

This figure shows the co-authorship network connecting the top 25 collaborators of Joel G. Berger. A scholar is included among the top collaborators of Joel G. Berger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joel G. Berger. Joel G. Berger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Berger, Joel G., et al.. (2000). Solid-Phase Synthesis of 2-Aminotetrahydropyrimidines. Synthetic Communications. 30(12). 2077–2082. 3 indexed citations
2.
Lachowicz, Jean E., Derek Lowe, Ruth A. Duffy, et al.. (1999). SCH 57790: A novel M2 receptor selective antagonist. Life Sciences. 64(6-7). 535–539. 19 indexed citations
3.
Berger, Joel G., et al.. (1998). Application of an almost traceless linker in the synthesis of 2-alkylthiobenzimidazole combinatorial libraries. Molecular Diversity. 4(4). 215–219. 7 indexed citations
4.
Bonhaus, Douglas W., Joel G. Berger, Nika Adham, et al.. (1997). [ 3 H]RS 57639, a High Affinity, Selective 5-HT 4 Receptor Partial Agonist, Specifically Labels Guinea-pig Striatal and Rat Cloned (5-HT 4S and 5-HT 4L ) Receptors. Neuropharmacology. 36(4-5). 671–679. 8 indexed citations
5.
Vaccaro, Wayne, Joel G. Berger, Robert E. Burrier, et al.. (1996). Inhibitors of Acyl CoA:Cholesterol Acyltransferase. Journal of Medicinal Chemistry. 39(8). 1704–1719. 39 indexed citations
6.
Clader, John W., Joel G. Berger, Robert E. Burrier, et al.. (1995). Substituted (1,2-Diarylethyl)amide Acyl-CoA:Cholesterol Acyltransferase Inhibitors: Effect of Polar Groups on in Vitro and in Vivo Activity. Journal of Medicinal Chemistry. 38(10). 1600–1607. 22 indexed citations
7.
Kozlowski, Joseph A., Derek Lowe, Henry Guzik, et al.. (1992). Dopamine receptor binding properties of some 2,3,4,5-tetrahydro-1H-3-benzazepine-7-ols with non-aromatic substituents in the 5-position. Bioorganic & Medicinal Chemistry Letters. 2(5). 399–402. 3 indexed citations
8.
9.
Chipkin, Richard E., Louis C. Iorio, Vicki L. Coffin, et al.. (1988). Pharmacological profile of SCH39166: a dopamine D1 selective benzonaphthazepine with potential antipsychotic activity.. Journal of Pharmacology and Experimental Therapeutics. 247(3). 1093–1102. 150 indexed citations
10.
Gingrich, Jay A., et al.. (1988). Affinity chromatography of the D1 dopamine receptor from rat corpus striatum. Biochemistry. 27(11). 3907–3912. 20 indexed citations
11.
Senogles, Susan E., et al.. (1988). Biochemical Properties of D1 and D2 Dopamine Receptors. Advances in experimental medicine and biology. 235. 33–41. 7 indexed citations
12.
Chipkin, Richard E., et al.. (1987). SCH 34826, the first orally active, enkephalinase inhibitor analgesic. Pain. 30. S254–S254. 3 indexed citations
13.
Amlaiky, N, et al.. (1986). Identification of the binding subunit of the D/sub 1/-dopamine receptor by photoaffinity crosslinking. Fed. Proc., Fed. Am. Soc. Exp. Biol.; (United States). 1 indexed citations
14.
Berger, Joel G.. (1972). The aluminum chloride promoted demethylation of some dimethoxyindoles. Two revised structures.. Tetrahedron Letters. 13(5). 393–394.
15.
Berger, Joel G., et al.. (1972). Reaction of pyrrole ketones with formaldehyde. Formation of N‐pyrrolemethanols. Journal of Heterocyclic Chemistry. 9(2). 419–421. 7 indexed citations
16.
Friedman, Lester, et al.. (1970). Carbenoid species from methyl and methylene halides. Journal of the American Chemical Society. 92(15). 4640–4645. 9 indexed citations
17.
Mislow, Kurt & Joel G. Berger. (1962). Dissymmetric Non-conjugated Chromophores. Optical Rotatory Dispersion of Bicyclo[2.2.1]hept-5-en-2-one and Bicyclo[2.2.2]oct-5-en-2-one. Journal of the American Chemical Society. 84(10). 1956–1961. 49 indexed citations
18.
Forster, Leslie S., Albert Moscowitz, Joel G. Berger, & Kurt Mislow. (1962). Inherently Dissymmetric Chromophores. Optical Activity Associated with a Homoconjugated Diene. Journal of the American Chemical Society. 84(22). 4353–4354. 15 indexed citations
19.
Friedman, Lester & Joel G. Berger. (1961). DEHYDROHALOGENATION OF SIMPLE ALKYL HALIDES BY STRONG BASE; EVIDENCE OF CARBENE INTERMEDIATES, EXTENT OF α-ELIMINATION1. Journal of the American Chemical Society. 83(2). 492–493. 18 indexed citations
20.
Friedman, Lester & Joel G. Berger. (1961). DEHYDROHALOGENATION OF NEOALKYL HALIDES BY STRONG BASE: EVIDENCE OF CARBENE INTERMEDIATES1. Journal of the American Chemical Society. 83(2). 500–501. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by William J. Houlihan Breakdown of academic impact, for papers by A. Walser Breakdown of academic impact, for papers by Jan W. F. Wasley Breakdown of academic impact, for papers by Clare O. Kneen Breakdown of academic impact, for papers by Waclaw J. Rzeszotarski Breakdown of academic impact, for papers by Graham J. Durant Breakdown of academic impact, for papers by Sham S. Nikam Breakdown of academic impact, for papers by Klaus P. Bøgesø Breakdown of academic impact, for papers by Steven Dabbs Breakdown of academic impact, for papers by Martyn C. Pritchard
Rankless by CCL
2026